Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 125 of 242 entries
View as:
Proton Therapy to Reduce Acute Normal Tissue Toxicity in Locally Advanced Non-small-cell Lung Cancer
Phase: N/A
Priority: Normal
Start: 08/31/16
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 04/12/21
End: 07/30/22
Due: 07/30/23
Phase: N/A
Priority: Normal
Start: 01/31/00
End: 11/30/12
Due: 11/30/13
Phase: N/A
Priority: Normal
Start: 03/31/03
End: 10/31/06
Due: 10/31/07
Phase: N/A
Priority: Normal
Start: 07/15/25
End: 12/31/28
Due: 12/31/29
Phase: N/A
Priority: Normal
Start: 09/30/04
End: 06/30/10
Due: 06/30/11
Phase: N/A
Priority: Normal
Start: 01/31/15
End: 01/31/16
Due: 01/31/17
Phase: N/A
Priority: Normal
Start: 07/01/24
End: 09/30/27
Due: 09/30/28
Phase: N/A
Priority: Normal
Start: 04/30/05
End: 10/31/05
Due: 10/31/06
Phase: N/A
Priority: Normal
Start: 01/31/05
End: 12/31/08
Due: 12/31/09
Phase: N/A
Priority: Normal
Start: 01/02/97
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 10/31/22
End: 12/31/29
Due: 12/31/30
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/29/96
End: 11/30/08
Due: 11/30/09
Phase: N/A
Priority: Normal
Start: 08/31/08
End: 01/31/12
Due: 01/31/13
Phase: N/A
Priority: Normal
Start: 12/31/12
End: 12/31/20
Due: 12/31/21
Phase: N/A
Priority: Normal
Start: 01/31/06
End: 03/31/07
Due: 03/31/08
Phase: N/A
Priority: Normal
Start: 07/31/05
End: 12/31/15
Due: 12/31/16
Phase: N/A
Priority: Normal
Start: 09/30/14
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 09/30/17
End: 07/01/21
Due: 07/01/22
Phase: N/A
Priority: Normal
Start: 03/31/13
End: 01/31/15
Due: 01/31/16
Phase: N/A
Priority: Normal
Start: 03/13/24
End: 12/31/30
Due: 12/31/31
Phase: N/A
Priority: Normal
Start: 05/01/17
End: 08/31/21
Due: 08/31/22
Phase: N/A
Priority: Normal
Start: 11/30/10
End: 01/31/12
Due: 01/31/13
Phase: N/A
Priority: Normal
Start: 11/30/10
End: 08/31/11
Due: 08/31/12